R
The startup is developing a rapid diagnostic platform that utilizes advanced microbial identification techniques and antimicrobial susceptibility testing directly from clinical samples. This technology enables healthcare providers to quickly determine the presence of specific pathogens and their resistance profiles, improving treatment decisions and patient outcomes.
Updated 20 months ago
Funding
$63.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IU
Funding rounds are not available yet.
Founders
Product
Features
- The startup is developing a rapid diagnostic platform that utilizes advanced microbial identification techniques and antimicrobial susceptibility testing directly from clinical samples. This technology enables healthcare providers to quickly determine the presence of specific pathogens and their resistance profiles, improving treatment decisions and patient outcomes.